KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)BEITELSHEES, Amber L; YAN GONG; JOHNSON, Julie A et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 9, pp 719-729, issn 1744-6872, 11 p.Article

Thin-layer chromatography-densitometry : Simultaneous high-performance thin-layer chromatography densitometric assay of trandolapril and verapamil in the combination preparationKOWALCZUK, Dorota.Journal of AOAC International. 2005, Vol 88, Num 5, pp 1525-1529, issn 1060-3271, 5 p.Article

Factors Influencing Blood Pressure Response to Trandolapril Add-On Therapy in Patients Taking Verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study)BRUNNER, Martin; COOPER-DEHOFF, Rhonda M; YAN GONG et al.The American journal of cardiology. 2007, Vol 99, Num 11, pp 1549-1554, issn 0002-9149, 6 p.Article

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en dIabéticos tipo Dos) studyRUILOPE, Luis M; USAN, Luis; SEGURA, Julian et al.Journal of hypertension. 2004, Vol 22, Num 1, pp 217-222, issn 0263-6352, 6 p.Article

Trandolapril: A newer angiotensin-converting enzyme inhibitorGUAY, David R.Clinical therapeutics. 2003, Vol 25, Num 3, pp 713-775, issn 0149-2918, 63 p.Article

Role of carboxylesterase 1 and impact of natural gene variants on the hydrolysis of trandolaprilZHU, Hao-Jie; APPEL, David I; JOHNSON, Julie A et al.Biochemical pharmacology. 2009, Vol 77, Num 7, pp 1266-1272, issn 0006-2952, 7 p.Article

The importance of sustained blood pressure controlMEREDITH, P. A.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 3, pp S7-S11Conference Paper

Verapamil SR and trandolapril combination therapy in hypertension : a clinical trial of factorial designSCHOLZE, J; ZILLES, P; COMPAGNONE, D et al.British journal of clinical pharmacology. 1998, Vol 45, Num 5, pp 491-495, issn 0306-5251Conference Paper

Α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes : Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)GERHARD, Tobias; YAN GONG; JOHNSON, Julie A et al.The American heart journal. 2008, Vol 156, Num 2, pp 397-404, issn 0002-8703, 8 p.Article

Comparison of suppression of the circulating and vascular renin-angiotensin system by Enalapril versus trandolapril in chronic heart failureJORDE, Ulrich P; VITTORIO, Timothy J; DIMAYUGA, Clarito A et al.The American journal of cardiology. 2004, Vol 94, Num 12, pp 1501-1505, issn 0002-9149, 5 p.Article

A calcium antagonist vs a non-calcium antagonist hypertension Treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trialPEPINE, Carl J; HANDBERG, Eileen M; ERDINE, Serap et al.JAMA, the journal of the American Medical Association. 2003, Vol 290, Num 21, pp 2805-2816, issn 0098-7484, 12 p.Article

Short-term effects of withdrawing inhibitor angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patientsVAUR, L; BOBRIE, G; DUTREY-DUPAGNE, C et al.American journal of hypertension. 1998, Vol 11, Num 2, pp 165-173, issn 0895-7061Article

Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension : A 4 x 4 trial designDEQUATTRO, V; LEE, D; MESSERLI, F et al.Clinical and experimental hypertension (1993). 1997, Vol 19, Num 3, pp 373-387, issn 1064-1963Article

A pharmacoepidemiologic study of trandolaprilJOUGLARD, J; HAMEL, J.-D; JUVIN, P et al.Current therapeutic research. 1997, Vol 58, Num 9, pp 555-563, issn 0011-393XArticle

Trandolapril et post-infactus = Trandolapril after myocardial infarctionLa Revue Prescrire. 1997, Vol 17, Num 172, pp 236-238, issn 0247-7750Article

Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])DENARDO, Scott J; MESSERLI, Franz H; GAXIOLA, Efrain et al.The American journal of cardiology. 2010, Vol 106, Num 4, pp 498-503, issn 0002-9149, 6 p.Article

Physicochemical characterization and decomposition kinetics of trandolaprilROUMELI, E; TSIAPRANT, A; KACHRIMANIS, K et al.Thermochimica acta. 2012, Vol 539, pp 92-99, issn 0040-6031, 8 p.Article

Trandolapril restores circadian blood pressure variation in normoalbuminuric normotensive Type 1 diabetic patientsCZUPRYNIAK, Leszek; WISNIEWSKA-JAROSINSKA, Maria; DRZEWOSKI, Jozef et al.Journal of diabetes and its complications. 2001, Vol 15, Num 2, pp 75-79, issn 1056-8727Article

Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal diseaseHEMMELDER, M. H; DE ZEEUW, D; DE JONG, P. E et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 1, pp 98-104, issn 0931-0509Conference Paper

Evaluation de l'influence du tabac sur la tolérance du trandolapril = Impact of smoking habits on safety profile of trandolaprilGENES, N; VAUR, L; ETIENNE, S et al.Thérapie (Paris). 1999, Vol 54, Num 6, pp 693-697, issn 0040-5957Conference Paper

Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trialsZOU, Z; XU, F.-Y; WANG, L et al.Journal of human hypertension. 2011, Vol 25, Num 3, pp 203-210, issn 0950-9240, 8 p.Article

Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapyRUBIO-GUERRA, Alberto Francisco; LOZANO-NUEVO, José Juan; VARGAS-AYALA, German et al.Clinical and experimental hypertension (1993). 2006, Vol 28, Num 7, pp 619-624, issn 1064-1963, 6 p.Article

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction : An INternational VErapamil SR-Trandolapril (INVEST) substudyBANGALORE, Sripal; MESSERLI, Franz H; COHEN, Jerome D et al.The American heart journal. 2008, Vol 156, Num 2, pp 241-247, issn 0002-8703, 7 p.Article

Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patientsNEW, J. P; MARSHALL, S. M; BILOUS, R. W et al.Diabetologia (Berlin). 1998, Vol 41, Num 2, pp 206-211, issn 0012-186XArticle

Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patientsVERSARI, D; VIRDIS, A; GHIADONI, L et al.Atherosclerosis. 2009, Vol 205, Num 1, pp 214-220, issn 0021-9150, 7 p.Article